Covered recipient · General Payments record
SUSAN M MCKELVEY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,658.31
- Reported across 117 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $823.87 | 43 |
| Debt forgiveness | $19.15 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $256.35 | 17 |
| ARGENX US, INC. | $61.92 | 3 |
| Lundbeck LLC | $61.63 | 3 |
| TG THERAPEUTICS, INC. | $58.51 | 2 |
| Lilly USA, LLC | $54.31 | 3 |
| Neurelis, Inc. | $41.11 | 2 |
| PFIZER INC. | $37.85 | 2 |
| SK Life Science, Inc. | $35.07 | 1 |
| LivaNova USA, Inc. | $33.99 | 2 |
| Alexion Pharmaceuticals, Inc. | $27.93 | 1 |
| Biogen, Inc. | $25.88 | 1 |
| EISAI INC. | $25.46 | 1 |
| Alnylam Pharmaceuticals Inc. | $24.06 | 1 |
| Merz Pharmaceuticals, LLC | $23.12 | 1 |
| Xeris Pharmaceuticals, Inc. | $20.97 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $20.96 | 1 |
| BAXTER HEALTHCARE | $19.15 | 1 |
| Teva Pharmaceuticals USA, Inc. | $14.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (44)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.58 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635282 | CMS |
| ABBVIE INC. | $12.23 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635284 | CMS |
| ABBVIE INC. | $10.46 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635286 | CMS |
| ABBVIE INC. | $31.11 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635288 | CMS |
| ABBVIE INC. | $16.97 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635290 | CMS |
| ABBVIE INC. | $11.53 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635292 | CMS |
| ABBVIE INC. | $14.38 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635294 | CMS |
| ABBVIE INC. | $14.08 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635296 | CMS |
| ABBVIE INC. | $22.62 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635298 | CMS |
| ABBVIE INC. | $6.67 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635300 | CMS |
| ABBVIE INC. | $33.63 | 07/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635302 | CMS |
| ABBVIE INC. | $8.90 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635304 | CMS |
| ABBVIE INC. | $3.00 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635306 | CMS |
| ABBVIE INC. | $12.28 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635308 | CMS |
| ABBVIE INC. | $8.34 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635310 | CMS |
| ABBVIE INC. | $7.72 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635312 | CMS |
| ABBVIE INC. | $20.85 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107635314 | CMS |
| Alexion Pharmaceuticals, Inc. | $27.93 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094019347 | CMS |
| Alnylam Pharmaceuticals Inc. | $24.06 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125846588 | CMS |
| ARGENX US, INC. | $28.67 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142148534 | CMS |
| ARGENX US, INC. | $13.60 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142152077 | CMS |
| ARGENX US, INC. | $19.65 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142151464 | CMS |
| Baxter Healthcare | $19.15 | 06/21/2024 | Debt forgiveness | Undisputed | 01/23/2026 | 1117802707 | CMS |
| Biogen, Inc. | $25.88 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104810769 | CMS |
| Eisai Inc. | $25.46 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110822733 | CMS |
| Lilly USA, LLC | $16.68 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135957345 | CMS |
| Lilly USA, LLC | $17.90 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135917651 | CMS |
| Lilly USA, LLC | $19.73 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135869278 | CMS |
| LivaNova USA, Inc. | $17.30 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789309 | CMS |
| LivaNova USA, Inc. | $16.69 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152789417 | CMS |
| Lundbeck LLC | $18.32 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146059392 | CMS |
| Lundbeck LLC | $23.28 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146059394 | CMS |
| Lundbeck LLC | $20.03 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146059396 | CMS |
| Merz Pharmaceuticals, LLC | $23.12 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137959954 | CMS |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $20.96 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144509990 | CMS |
| Neurelis, Inc. | $21.83 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145667369 | CMS |
| Neurelis, Inc. | $19.28 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145667371 | CMS |
| PFIZER INC. | $19.60 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132081482 | CMS |
| PFIZER INC. | $18.25 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132089631 | CMS |
| SK Life Science, Inc. | $35.07 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154127718 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.75 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151753786 | CMS |
| TG Therapeutics, Inc. | $20.09 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136876544 | CMS |
| TG Therapeutics, Inc. | $38.42 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136876672 | CMS |
| Xeris Pharmaceuticals, Inc. | $20.97 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144639436 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.